Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Ojesina, AI"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-12 z 12
    Tytuł:
    Genomic Characterization and Therapeutic Targeting of HPV Undetected Cervical Carcinomas.
    Autorzy:
    Ruiz FJ; Division of Biological and Biomedical Sciences Molecular Cell Biology, Washington University School of Medicine, St. Louis, MO 63108, USA.; Department of Radiation Oncology, Washington University School of Medicine, St. Louis, MO 63108, USA.
    Sundaresan A; Department of Biostatistics, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
    Zhang J; Department of Radiation Oncology, Washington University School of Medicine, St. Louis, MO 63108, USA.; Institute for Informatics, Washington University School of Medicine, St. Louis, MO 63108, USA.; Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO 63108, USA.
    Pedamallu CS; Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
    Halle MK; Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.; Department of Obstetrics and Gynaecology, Haukeland University Hospital, 5021 Bergen, Norway.; Centre for Cancer Biomarkers, Department of Clinical Science, University of Bergen, 5020 Bergen, Norway.
    Srinivasasainagendra V; Department of Biostatistics, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
    Zhang J; Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.; O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
    Muhammad N; Department of Radiation Oncology, Washington University School of Medicine, St. Louis, MO 63108, USA.
    Stanley J; Department of Radiation Oncology, Washington University School of Medicine, St. Louis, MO 63108, USA.; Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO 63108, USA.
    Markovina S; Department of Radiation Oncology, Washington University School of Medicine, St. Louis, MO 63108, USA.; Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO 63108, USA.
    Tiwari HK; Department of Biostatistics, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
    Grigsby PW; Department of Radiation Oncology, Washington University School of Medicine, St. Louis, MO 63108, USA.; Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO 63108, USA.
    Krakstad C; Department of Obstetrics and Gynaecology, Haukeland University Hospital, 5021 Bergen, Norway.; Centre for Cancer Biomarkers, Department of Clinical Science, University of Bergen, 5020 Bergen, Norway.
    Schwarz JK; Division of Biological and Biomedical Sciences Molecular Cell Biology, Washington University School of Medicine, St. Louis, MO 63108, USA.; Department of Radiation Oncology, Washington University School of Medicine, St. Louis, MO 63108, USA.; Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO 63108, USA.; Department of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, MO 63108, USA.
    Ojesina AI; Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.; O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL 35294, USA.; HudsonAlpha Institute for Biotechnology, Huntsville, AL 35806, USA.
    Pokaż więcej
    Źródło:
    Cancers [Cancers (Basel)] 2021 Sep 10; Vol. 13 (18). Date of Electronic Publication: 2021 Sep 10.
    Typ publikacji:
    Journal Article
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Immunophenotype-associated gene signature in ductal breast tumors varies by receptor subtype, but the expression of individual signature genes remains consistent.
    Autorzy:
    Behring M; Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, USA.; Department of Pathology and Surgery, University of Alabama at Birmingham, Birmingham, AL, USA.
    Ye Y; Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, USA.
    Elkholy A; Department of Pathology and Surgery, University of Alabama at Birmingham, Birmingham, AL, USA.
    Bajpai P; Department of Pathology and Surgery, University of Alabama at Birmingham, Birmingham, AL, USA.
    Agarwal S; Department of Pathology and Surgery, University of Alabama at Birmingham, Birmingham, AL, USA.
    Kim HG; Department of Pathology and Surgery, University of Alabama at Birmingham, Birmingham, AL, USA.
    Ojesina AI; Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, USA.; Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, USA.
    Wiener HW; Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, USA.
    Manne U; Department of Pathology and Surgery, University of Alabama at Birmingham, Birmingham, AL, USA.; Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, USA.
    Shrestha S; Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, USA.
    Vazquez AI; Department of Epidemiology and Biostatistics, Michigan State University, East Lansing, MI, USA.; Institute for Quantitative Health Science & Engineering, East Lansing, MI, USA.
    Pokaż więcej
    Źródło:
    Cancer medicine [Cancer Med] 2021 Aug; Vol. 10 (16), pp. 5712-5720. Date of Electronic Publication: 2021 Jun 29.
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural
    MeSH Terms:
    Biomarkers, Tumor/*metabolism
    Breast Neoplasms/*immunology
    Carcinoma, Ductal, Breast/*immunology
    Gene Expression Regulation, Neoplastic/*immunology
    Lymphocytes, Tumor-Infiltrating/*immunology
    Breast Neoplasms/genetics ; Breast Neoplasms/pathology ; Carcinoma, Ductal, Breast/genetics ; Carcinoma, Ductal, Breast/pathology ; Datasets as Topic ; Female ; Gene Expression Profiling ; Humans ; Immunophenotyping ; Lymphocytes, Tumor-Infiltrating/metabolism ; Up-Regulation/immunology
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Dissection of PIK3CA Aberration for Cervical Adenocarcinoma Outcomes.
    Autorzy:
    Chung TKH; The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong.
    Doran G; Firefly Bioworks, Inc., Cambridge, MA 02139, USA.
    Cheung TH; The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong.
    Yim SF; The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong.
    Yu MY; The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong.
    Worley MJ Jr; Harvard Medical School, Brigham and Women's Hospital, Boston, MA 02115, USA.
    Elias KM; Harvard Medical School, Brigham and Women's Hospital, Boston, MA 02115, USA.
    Thorner AR; Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA 02115, USA.
    Pedamallu CS; Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
    Ojesina AI; Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
    Lau KM; The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong.
    Ducar MD; Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA 02115, USA.
    Wong RRY; The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong.
    Wang VW; Mayo Clinic, Rochester, MN 55902, USA.
    Nag A; Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA 02115, USA.
    Wollison BM; Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA 02115, USA.
    Dalgarno A; Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA 02115, USA.
    Lee JHS; The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong.
    Yeung SY; The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong.
    Wong L; The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong.
    Horowitz NS; Harvard Medical School, Brigham and Women's Hospital, Boston, MA 02115, USA.
    Davis MR; Harvard Medical School, Brigham and Women's Hospital, Boston, MA 02115, USA.
    Leung SA; Harvard Medical School, Brigham and Women's Hospital, Boston, MA 02115, USA.
    Mu Y; Harvard Medical School, Brigham and Women's Hospital, Boston, MA 02115, USA.
    Mok SC; MD Anderson Cancer Center, The University of Texas, Houston, TX 77030, USA.
    Chan PKS; The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong.
    Lawrence MS; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.; Harvard Medical School, Massachusetts General Hospital, Boston, MA 02114, USA.
    Crum CP; Harvard Medical School, Brigham and Women's Hospital, Boston, MA 02115, USA.
    Chiu RWK; The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong.
    Berkowitz RS; Harvard Medical School, Brigham and Women's Hospital, Boston, MA 02115, USA.
    Wong YF; The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong.; Harvard Medical School, Brigham and Women's Hospital, Boston, MA 02115, USA.
    Pokaż więcej
    Źródło:
    Cancers [Cancers (Basel)] 2021 Jun 28; Vol. 13 (13). Date of Electronic Publication: 2021 Jun 28.
    Typ publikacji:
    Journal Article
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    HPV-EM: an accurate HPV detection and genotyping EM algorithm.
    Autorzy:
    Inkman MJ; Department of Radiation Oncology, Washington University School of Medicine, St. Louis, MO, 63108, USA.
    Jayachandran K; Department of Radiation Oncology, Washington University School of Medicine, St. Louis, MO, 63108, USA.
    Ellis TM; Department of Radiation Oncology, Washington University School of Medicine, St. Louis, MO, 63108, USA.; Department of Computer Science, Washington University in St. Louis, St. Louis, MO, 63105, USA.
    Ruiz F; Department of Radiation Oncology, Washington University School of Medicine, St. Louis, MO, 63108, USA.
    McLellan MD; McDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO, 63108, USA.
    Miller CA; McDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO, 63108, USA.
    Wu Y; Computer Science and Engineering Department, University of Connecticut, Storrs, CT, 06269, USA.
    Ojesina AI; Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, 35294, USA.; O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, 35294, USA.; Hudson-Alpha Institute for Biotechnology, Huntsville, AL, 35806, USA.
    Schwarz JK; Department of Radiation Oncology, Washington University School of Medicine, St. Louis, MO, 63108, USA.; Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO, 63108, USA.; Department of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, MO, 63108, USA.
    Zhang J; Department of Radiation Oncology, Washington University School of Medicine, St. Louis, MO, 63108, USA. .; Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO, 63108, USA. .; Institute for Informatics, Washington University School of Medicine, St. Louis, MO, 63108, USA. .
    Pokaż więcej
    Źródło:
    Scientific reports [Sci Rep] 2020 Aug 31; Vol. 10 (1), pp. 14340. Date of Electronic Publication: 2020 Aug 31.
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
    MeSH Terms:
    Algorithms*
    Genes, Viral*
    Genotype*
    Alphapapillomavirus/*genetics
    Female ; Head and Neck Neoplasms/virology ; Humans ; Reproducibility of Results ; Uterine Cervical Neoplasms/virology
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Gain of function in somatic TP53 mutations is associated with immune-rich breast tumors and changes in tumor-associated macrophages.
    Autorzy:
    Behring M; Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, USA.; Department of Pathology and Surgery, University of Alabama at Birmingham, Birmingham, AL, USA.
    Vazquez AI; Institute for Quantitative Health Science and Engineering, Michigan State University, East Lansing, MI, USA.; Department of Epidemiology and Biostatistics, Michigan State University, East Lansing, MI, USA.
    Cui X; Department of Biostatistics and Bioinformatics, Emory University, Atlanta, GA, USA.
    Irvin MR; Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, USA.
    Ojesina AI; Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, USA.; HudsonAlpha Institute for Biotechnology, Huntsville, AL, USA.; Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, USA.
    Agarwal S; Department of Pathology and Surgery, University of Alabama at Birmingham, Birmingham, AL, USA.
    Manne U; Department of Pathology and Surgery, University of Alabama at Birmingham, Birmingham, AL, USA.; Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, USA.
    Shrestha S; Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, USA.; Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, USA.
    Pokaż więcej
    Źródło:
    Molecular genetics & genomic medicine [Mol Genet Genomic Med] 2019 Dec; Vol. 7 (12), pp. e1001. Date of Electronic Publication: 2019 Oct 22.
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural
    MeSH Terms:
    Gain of Function Mutation*
    Breast Neoplasms/*immunology
    Macrophages/*metabolism
    Tumor Suppressor Protein p53/*genetics
    Aged ; Breast Neoplasms/genetics ; Breast Neoplasms/pathology ; Female ; Humans ; Middle Aged ; Neoplasm Staging
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Landscape of genomic alterations in cervical carcinomas.
    Autorzy:
    Ojesina AI; 1] Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA [2] The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts 02142, USA [3].
    Lichtenstein L; 1] The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts 02142, USA [2].
    Freeman SS; The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts 02142, USA.
    Pedamallu CS; 1] Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA [2] The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts 02142, USA.
    Imaz-Rosshandler I; Instituto Nacional de Medicina Genomica, Mexico City 14610, Mexico.
    Pugh TJ; 1] Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA [2] The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts 02142, USA.
    Cherniack AD; The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts 02142, USA.
    Ambrogio L; The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts 02142, USA.
    Cibulskis K; The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts 02142, USA.
    Bertelsen B; Department of Pathology, Haukeland University Hospital, N5021 Bergen, Norway.
    Romero-Cordoba S; Instituto Nacional de Medicina Genomica, Mexico City 14610, Mexico.
    Treviño V; Tecnológico de Monterrey, Monterrey 64849, Mexico.
    Vazquez-Santillan K; Instituto Nacional de Medicina Genomica, Mexico City 14610, Mexico.
    Guadarrama AS; Instituto Nacional de Medicina Genomica, Mexico City 14610, Mexico.
    Wright AA; 1] Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA [2] Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA.
    Rosenberg MW; The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts 02142, USA.
    Duke F; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA.
    Kaplan B; 1] Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA [2] The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts 02142, USA.
    Wang R; 1] Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA [2] Department of Thoracic Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
    Nickerson E; The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts 02142, USA.
    Walline HM; Cancer Biology Program, Program in the Biomedical Sciences, Rackham Graduate School, University of Michigan, Ann Arbor, Michigan 48109, USA.
    Lawrence MS; The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts 02142, USA.
    Stewart C; The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts 02142, USA.
    Carter SL; The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts 02142, USA.
    McKenna A; The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts 02142, USA.
    Rodriguez-Sanchez IP; Facultad de Medicina y Hospital Universitario 'Dr. José Eluterio González' de la Universidad Autónoma de Nuevo León, Monterrey, Nuevo León 64460, México.
    Espinosa-Castilla M; Instituto Nacional de Medicina Genomica, Mexico City 14610, Mexico.
    Woie K; Department of Obstetrics and Gynecology, Haukeland University Hospital, N5021 Bergen, Norway.
    Bjorge L; 1] Department of Obstetrics and Gynecology, Haukeland University Hospital, N5021 Bergen, Norway [2] Department of Clinical Science, Centre for Cancer Biomarkers, University of Bergen, N5020 Bergen, Norway.
    Wik E; 1] Department of Obstetrics and Gynecology, Haukeland University Hospital, N5021 Bergen, Norway [2] Department of Clinical Science, Centre for Cancer Biomarkers, University of Bergen, N5020 Bergen, Norway.
    Halle MK; 1] Department of Obstetrics and Gynecology, Haukeland University Hospital, N5021 Bergen, Norway [2] Department of Clinical Science, Centre for Cancer Biomarkers, University of Bergen, N5020 Bergen, Norway.
    Hoivik EA; 1] Department of Obstetrics and Gynecology, Haukeland University Hospital, N5021 Bergen, Norway [2] Department of Clinical Science, Centre for Cancer Biomarkers, University of Bergen, N5020 Bergen, Norway.
    Krakstad C; 1] Department of Obstetrics and Gynecology, Haukeland University Hospital, N5021 Bergen, Norway [2] Department of Clinical Science, Centre for Cancer Biomarkers, University of Bergen, N5020 Bergen, Norway.
    Gabiño NB; Instituto Nacional de Medicina Genomica, Mexico City 14610, Mexico.
    Gómez-Macías GS; Facultad de Medicina y Hospital Universitario 'Dr. José Eluterio González' de la Universidad Autónoma de Nuevo León, Monterrey, Nuevo León 64460, México.
    Valdez-Chapa LD; Facultad de Medicina y Hospital Universitario 'Dr. José Eluterio González' de la Universidad Autónoma de Nuevo León, Monterrey, Nuevo León 64460, México.
    Garza-Rodríguez ML; Facultad de Medicina y Hospital Universitario 'Dr. José Eluterio González' de la Universidad Autónoma de Nuevo León, Monterrey, Nuevo León 64460, México.
    Maytorena G; Instituto Mexicano del Seguro Social, Mexico City 06720, Mexico.
    Vazquez J; Instituto Mexicano del Seguro Social, Mexico City 06720, Mexico.
    Rodea C; Instituto Mexicano del Seguro Social, Mexico City 06720, Mexico.
    Cravioto A; Instituto Mexicano del Seguro Social, Mexico City 06720, Mexico.
    Cortes ML; The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts 02142, USA.
    Greulich H; 1] Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA [2] The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts 02142, USA [3] Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA.
    Crum CP; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA.
    Neuberg DS; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA.
    Hidalgo-Miranda A; Instituto Nacional de Medicina Genomica, Mexico City 14610, Mexico.
    Escareno CR; 1] Instituto Nacional de Medicina Genomica, Mexico City 14610, Mexico [2] Claremont Graduate University, Claremont, California 91711, USA.
    Akslen LA; 1] Department of Pathology, Haukeland University Hospital, N5021 Bergen, Norway [2] Centre for Cancer Biomarkers, Department of Clinical Medicine, University of Bergen, N5020 Bergen, Norway.
    Carey TE; Head and Neck Oncology Program and Department of Otolaryngology, University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan 38109, USA.
    Vintermyr OK; 1] Department of Pathology, Haukeland University Hospital, N5021 Bergen, Norway [2] Centre for Cancer Biomarkers, Department of Clinical Medicine, University of Bergen, N5020 Bergen, Norway.
    Gabriel SB; The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts 02142, USA.
    Barrera-Saldaña HA; Facultad de Medicina y Hospital Universitario 'Dr. José Eluterio González' de la Universidad Autónoma de Nuevo León, Monterrey, Nuevo León 64460, México.
    Melendez-Zajgla J; Instituto Nacional de Medicina Genomica, Mexico City 14610, Mexico.
    Getz G; 1] The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts 02142, USA [2] Massachusetts General Hospital Cancer Center and Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, USA.
    Salvesen HB; 1] Department of Obstetrics and Gynecology, Haukeland University Hospital, N5021 Bergen, Norway [2] Department of Clinical Science, Centre for Cancer Biomarkers, University of Bergen, N5020 Bergen, Norway [3].
    Meyerson M; 1] Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA [2] The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts 02142, USA [3] Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA [4].
    Pokaż więcej
    Źródło:
    Nature [Nature] 2014 Feb 20; Vol. 506 (7488), pp. 371-5. Date of Electronic Publication: 2013 Dec 25.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Genome, Human/*genetics
    Mutation/*genetics
    Uterine Cervical Neoplasms/*genetics
    Adenocarcinoma/genetics ; Adenocarcinoma/virology ; Carcinoma, Squamous Cell/genetics ; Carcinoma, Squamous Cell/virology ; Case-Control Studies ; Cell Cycle Proteins/genetics ; Core Binding Factor beta Subunit/genetics ; DNA Copy Number Variations/genetics ; DNA Mutational Analysis ; DNA-Binding Proteins/genetics ; E1A-Associated p300 Protein/genetics ; Exome/genetics ; F-Box Proteins/genetics ; F-Box-WD Repeat-Containing Protein 7 ; Female ; Gene Expression Regulation, Neoplastic/genetics ; Genomics ; HLA-B Antigens/genetics ; Humans ; Mitogen-Activated Protein Kinase 1/genetics ; NF-E2-Related Factor 2/genetics ; Papillomaviridae/genetics ; Papillomaviridae/physiology ; Papillomavirus Infections/genetics ; Proto-Oncogene Proteins/genetics ; Proto-Oncogene Proteins c-ets ; Receptor, ErbB-2/genetics ; Transcription Factors/genetics ; Transcriptome/genetics ; Tumor Suppressor Protein p53/genetics ; Ubiquitin-Protein Ligases/genetics ; Uterine Cervical Neoplasms/virology ; Virus Integration/genetics
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    PathSeq: software to identify or discover microbes by deep sequencing of human tissue.
    Autorzy:
    Kostic AD
    Ojesina AI
    Pedamallu CS
    Jung J
    Verhaak RG
    Getz G
    Meyerson M
    Pokaż więcej
    Źródło:
    Nature biotechnology [Nat Biotechnol] 2011 May; Vol. 29 (5), pp. 393-6.
    Typ publikacji:
    Letter; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Genome, Human*
    Software*
    High-Throughput Nucleotide Sequencing/*methods
    Sequence Analysis, RNA/*methods
    Computational Biology ; Databases, Nucleic Acid ; Gene Library ; Genome, Viral ; HeLa Cells ; Human papillomavirus 18/isolation & purification ; Humans
    Raport
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    HIV-1 subtype and reverse transcriptase genotype: role for geographical location and founder effects.
    Autorzy:
    Ojesina AI
    Kanki PJ
    Pokaż więcej
    Źródło:
    PLoS medicine [PLoS Med] 2006 Dec; Vol. 3 (12), pp. e540.
    Typ publikacji:
    Comment; Letter
    MeSH Terms:
    HIV Infections/*genetics
    HIV-1/*genetics
    RNA-Directed DNA Polymerase/*genetics
    Anti-Retroviral Agents ; Drug Resistance, Viral ; HIV-1/pathogenicity ; Humans ; Nigeria ; Polymorphism, Genetic ; Portugal ; Spain
    Opinia redakcyjna
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Decline in the frequency of Burkitt's lymphoma relative to other childhood malignancies in Ibadan, Nigeria.
    Autorzy:
    Ojesina AI; Postgraduate Institute of Medical Research & Training, University College Hospital, Ibadan, Nigeria.
    Akang EE
    Ojemakinde KO
    Pokaż więcej
    Źródło:
    Annals of tropical paediatrics [Ann Trop Paediatr] 2002 Jun; Vol. 22 (2), pp. 159-63.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Burkitt Lymphoma/*epidemiology
    Adolescent ; Age Distribution ; Child ; Child, Preschool ; Female ; Humans ; Infant ; Infant, Newborn ; Male ; Neoplasms/epidemiology ; Nigeria/epidemiology ; Prevalence ; Registries ; Retrospective Studies ; Sex Distribution
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
      Wyświetlanie 1-12 z 12

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies